Advertisement

Parasitology Research

, 109:793 | Cite as

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

  • Amir Mizbani
  • Yasaman Taslimi
  • Farnaz Zahedifard
  • Tahereh Taheri
  • Sima Rafati
Original Paper

Abstract

Several species of protozoan parasites of the genus Leishmania are pathogenic to mammals and cause a wide spectrum of pathologies in human. However, the genus includes some species which infect reptiles. Leishmania tarentolae is a lizard pathogen absolutely nonpathogenic to mammals. Recent studies have shown that among some major virulence factors, A2 is absent in this species. First identified as an amastigote-specific gene in Leishmania donovani, A2 has been proved to play a major role in parasite virulence and visceralization capability. In this study, we have transfected A2 episomally into L. tarentolae and evaluated its effect on infectivity and survival of the parasites, in vitro and in vivo. During infection of in vitro-cultured intraperitoneal macrophages of BALB/c mice, A2-expressing L. tarentolae parasites demonstrated significantly higher level of infectivity in days 3 and 4 post-infection in comparison with the wild-type strain as control. Furthermore, in vivo infection showed that A2 has significantly increased the ability of L. tarentolae to survive in the liver of BALB/c mice. Altogether, our results show that A2 is functional in L. tarentolae, although through an unknown mechanism, and loss of A2 has been one of the factors partly contributing to the loss of virulence of L. tarentolae.

Keywords

Leishmaniasis Parasite Load Visceral Organ Parasite Burden Leishmania Species 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Azizi H, Hassani K, Taslimi Y, Shateri Najafabadi H, Papadopoulou B, Rafati S (2009) Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae. Parasitology 136:723–735PubMedCrossRefGoogle Scholar
  2. Badaro R, Jones TC, Carvalho EM (1986) New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154:1003–1011PubMedCrossRefGoogle Scholar
  3. Bogdan C, Röllinghoff M (1999) How do protozoan parasites survive inside macrophages? Parasitol Today 15:22–28PubMedCrossRefGoogle Scholar
  4. Breton M, Tremblay MJ, Ouellette M, Papadopoulou B (2005) Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun 73:6372–6382PubMedCrossRefGoogle Scholar
  5. Briones MRS, Nelson K, Beverley SM, Affonso HT, Camargo EP, Floeter-Winter LM (1992) Leishmania tarentolae taxonomic relatedness inferred from phylogenetic analysis of the small subunit ribosomal RNA gene. Mol Biochem Parasitol 53:121–128PubMedCrossRefGoogle Scholar
  6. Chang KP, Chaudhuri G, Fong D (1990) Molecular determinants of Leishmania virulence. Annu Rev Microbiol 44:499–529PubMedCrossRefGoogle Scholar
  7. Chang KP, Akman L, Nielsen JS (1999) Leishmania virulence and genetic heterogeneity. Clin Dermatol 17:269–273PubMedCrossRefGoogle Scholar
  8. Chang K, Reed SG, McGwire BS, Soong L (2003) Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop 85:375–380PubMedCrossRefGoogle Scholar
  9. Charest H, Matlashewski G (1994) Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote stage-specific gene. Mol Cell Biol 14:2975–2984PubMedGoogle Scholar
  10. Croan DG, Morrison DA, Ellis JT (1997) Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Mol Biochem Parasitol 89:149–159PubMedCrossRefGoogle Scholar
  11. Desjeux P (2004) Leishmaniasis. Nat Rev Microbiol 2:692–693PubMedCrossRefGoogle Scholar
  12. Fu G, Kolesnikov AA (1994) Leishmania gymnodactyli and Leishmania infantum minicircles contain the same guide RNA genes as do minicircles of Leishmania tarentolae. Mol Biochem Parasitol 67:171–174PubMedCrossRefGoogle Scholar
  13. Garin YJ, Meneceur P, Pratlong F, Dedet JP, Derouin F, Lorenzo F (2005) A2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene. BMC Infect Dis 5:18. doi: 10.1186/1471-2334-5-18 PubMedCrossRefGoogle Scholar
  14. Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, Matlashewski G (1997) Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 4:530–535PubMedGoogle Scholar
  15. Gomez-Eichelmann MC, Holz G Jr, Beach D, Simpson AM, Simpson L (1988) Comparison of several lizard Leishmania species and strains in terms of kinetoplast minicircle and maxicircle DNA sequences, nuclear chromosomes, and membrane lipids. Mol Biochem Parasitol 27:143–158PubMedCrossRefGoogle Scholar
  16. Lainson R, Shaw JJ (1987) Evolution, classification and geographical distribution of Leishmania. In: Peters W, Killick-Kendrick R (eds) The leishmaniasis in biology and medicine. Academic, London, pp 1–120Google Scholar
  17. Luyo-Acero GE, Uezato H, Oshiro M, Takei K, Kariya K, Katakura K, Gomez EAL, Hashiguchi Y, Nonaka S (2004) Sequence variation of the cytochrome b gene of various human infecting members of the genus Leishmania and their phylogeny. Parasitology 128:483–491PubMedCrossRefGoogle Scholar
  18. McCall L, Matlashewski G (2010) Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol Microbiol 77:518–530PubMedCrossRefGoogle Scholar
  19. Mizbani A, Taheri T, Zahedifard F, Taslimi Y, Azizi H, Azadmanesh K, Papadopoulou B, Rafati S (2010) Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis. Vaccine 28:53–62CrossRefGoogle Scholar
  20. Molyneux DH, Ashford RW (1983) The biology of Trypanosoma and Leishmania, parasites of man and domestic animals. Taylor & Francis, LondonGoogle Scholar
  21. Pearson RD, De Queiroz Sousa A (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1–13PubMedCrossRefGoogle Scholar
  22. Prina E, Roux E, Mattei D, Milon G (2007) Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microbes Infect 9:1307–1315PubMedCrossRefGoogle Scholar
  23. Probst P, Stromberg E, Ghalib HW, Mozel M, Badaro R, Reed SG, Webb JR (2001) Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol 166:498–505PubMedGoogle Scholar
  24. Rafati S, Zahedifard F, Nazgouee F (2006) Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis. Vaccine 24:2169–2175PubMedCrossRefGoogle Scholar
  25. Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM (2002) Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 18:421–426PubMedCrossRefGoogle Scholar
  26. Requena JM, Alonso C, Soto M (2000) Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today 16:246–250PubMedCrossRefGoogle Scholar
  27. Rittig MG, Bogdan C (2000) Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16:292–297PubMedCrossRefGoogle Scholar
  28. Sereno DE, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A (2007) Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int 56:3–7PubMedCrossRefGoogle Scholar
  29. Shaw JJ (1994) Taxonomy of the genus Leishmania: present and future trends and their implications. Mem Inst Oswaldo Cruz 89:471–478PubMedCrossRefGoogle Scholar
  30. Silvestre R, Cordeiro-Da-Silva A, Santarém N, Vergnes B, Sereno D, Ouaissi A (2007) SIR2-deficient Leishmania infantum induces a defined IFN-γ/IL-10 pattern that correlates with protection. J Immunol 179:3161–3170PubMedGoogle Scholar
  31. Wallbanks K, Maazoun R, Canning EU, Rioux JA (1985) The identity of Leishmania tarentolae Wenyon 1921. Parasitology 90:67–78PubMedCrossRefGoogle Scholar
  32. Wenyon DM (1921) Observations on the intestinal protozoa of three Egyptian lizards, with a note on a cell-invading fungus. Parasitology 12:133–140Google Scholar
  33. World Health Organization (1990a) Control of the Leishmaniasis. WHO Expert Committee Technical Report Series No. 793. World Health Organization, GenevaGoogle Scholar
  34. World Health Organization (1990b) The Leishmaniasis. WHO Expert Committee Technical Report Series No. 793. World Health Organization, GenevaGoogle Scholar
  35. Zhang WW, Matlashewski G (1997) Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci USA 94:8807–8811PubMedCrossRefGoogle Scholar
  36. Zhang WW, Matlashewski G (2001) Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 39:935–948PubMedCrossRefGoogle Scholar
  37. Zhang W, Charest H, Ghedin E, Matlashewski G (1996) Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani. Mol Biochem Parasitol 78:79–90PubMedCrossRefGoogle Scholar
  38. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, Clos J, Sacks DL, Matlashewski G (2003) Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection. J Biol Chem 278:35508–35515PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Amir Mizbani
    • 1
    • 2
  • Yasaman Taslimi
    • 1
  • Farnaz Zahedifard
    • 1
  • Tahereh Taheri
    • 1
  • Sima Rafati
    • 1
  1. 1.Molecular Immunology and Vaccine Research LaboratoryPasteur Institute of IranTehranIran
  2. 2.Department of Biotechnology, University College of ScienceUniversity of TehranTehranIran

Personalised recommendations